MSD beats revenue expectations amid pivot to new drugs

MSD Ireland's fill site at Carlow employs almost 530 staff.

MSD beat third-quarter sales expectations on strong results from its pneumonia vaccine as the company works to find new growth drivers ahead of the upcoming patent loss for its star drug Keytruda.

The drugmaker, known as Merck & Co in the US and Canada, operates eight sites across Ireland, located in Carlow, Cork, Dublin, Meath, Louth and Tipperary.